Cargando…
Blocking the ZZ Domain of Sequestosome1/p62 Suppresses Myeloma Growth and Osteoclast Formation In Vitro and Induces Dramatic Bone Formation in Myeloma-Bearing Bones In Vivo
We reported that p62 (sequestosome 1) serves as a signaling hub in bone marrow stromal cells (BMSC) for the formation of signaling complexes, including NFκB, p38MAPK, and JNK, that are involved in the increased osteoclastogenesis and multiple myeloma (MM) cell growth induced by BMSC that are key con...
Autores principales: | Teramachi, Jumpei, Silbermann, Rebecca, Yang, Peng, Zhao, Wei, Mohammad, Khalid S., Guo, Jianxia, Anderson, Judith L., Zhou, Dan, Feng, Rentian, Myint, Kyaw-Zeyar, Maertz, Nathan, Beumer, Jan H., Eiseman, Julie L., Windle, Jolene J., Xie, Xiang-Qun, Roodman, G. David, Kurihara, Noriyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740189/ https://www.ncbi.nlm.nih.gov/pubmed/26286116 http://dx.doi.org/10.1038/leu.2015.229 |
Ejemplares similares
-
Myeloma bone disease: Pathophysiology and management
por: Silbermann, Rebecca, et al.
Publicado: (2013) -
Bone Marrow Monocyte / Macrophage Derived Activin A Mediates the Osteoclastogenic Effect of IL-3 in Multiple Myeloma
por: Silbermann, Rebecca, et al.
Publicado: (2013) -
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors
por: Nakaue, Emiko, et al.
Publicado: (2023) -
Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease
por: Nagata, Yuki, et al.
Publicado: (2020) -
Osteoblast suppression in multiple myeloma bone disease
por: Adamik, Juraj, et al.
Publicado: (2018)